A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
Browsing: Preventive Medicine
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
Jody Ciolino, PhD, and Masha Kocherginsky, PhD, faculty in the Department of Preventive Medicine Division of Biostatistics, were elected to the Board of Directors for the Society for Clinical Trials (SCT).
Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.
Northwestern and the American Lung Association have begun a first-of-its-kind longitudinal study to track and analyze the lungs of millennials at the peak of their lung health.
Jeremiah Stamler, MD, founding chair and professor emeritus of Preventive Medicine, passed away on January 26. He was 102 years old.
Michael Wang, a fourth-year medical student, is the lead author of a study recently selected by the American Heart Association as one of the top heart disease and stroke research advances of 2021.
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.
Donald Lloyd-Jones, MD, ScM, chair of Preventive Medicine and the Eileen M. Foell Professor of Heart Research, and current president of the American Heart Association, recently testified before Congress in support of legislation that would improve cardiovascular health in the U.S.
Epigenetic aging could serve as a promising biomarker for measuring long-term cardiovascular health and disease risk, according to a recent Northwestern Medicine study.